Kristin A Evans1, Jill S Halterman2, Philip K Hopke3, Maria Fagnano4, David Q Rich5. 1. Department of Public Health Sciences, University of Rochester School of Medicine & Dentistry, 265 Crittenden Boulevard, CU 420644, Rochester, NY 14642, USA. Electronic address: kristin_evans@urmc.rochester.edu. 2. Department of Pediatrics, University of Rochester School of Medicine & Dentistry, 601 Elmwood Avenue, Box 777, Rochester, NY 14642, USA. Electronic address: jill_halterman@urmc.rochester.edu. 3. Department of Chemical & Biomolecular Engineering, CA206 CAMP/Rowley Annex, Clarkson University, PO Box 5708, Potsdam, NY 13699, USA. Electronic address: hopkepk@clarkson.edu. 4. Department of Pediatrics, University of Rochester School of Medicine & Dentistry, 601 Elmwood Avenue, Box 777, Rochester, NY 14642, USA. Electronic address: maria_fagnano@urmc.rochester.edu. 5. Department of Public Health Sciences, University of Rochester School of Medicine & Dentistry, 265 Crittenden Boulevard, CU 420644, Rochester, NY 14642, USA. Electronic address: david_rich@urmc.rochester.edu.
Abstract
OBJECTIVES: Increased air pollutant concentrations have been linked to several asthma-related outcomes in children, including respiratory symptoms, medication use, and hospital visits. However, few studies have examined effects of ultrafine particles in a pediatric population. Our primary objective was to examine the effects of ambient concentrations of ultrafine particles on asthma exacerbation among urban children and determine whether consistent treatment with inhaled corticosteroids could attenuate these effects. We also explored the relationship between asthma exacerbation and ambient concentrations of accumulation mode particles, fine particles (≤2.5 micrograms [μm]; PM2.5), carbon monoxide, sulfur dioxide, and ozone. We hypothesized that increased 1-7 day concentrations of ultrafine particles and other pollutants would be associated with increases in the relative odds of an asthma exacerbation, but that this increase in risk would be attenuated among children receiving school-based corticosteroid therapy. METHODS: We conducted a pilot study using data from 3 to 10 year-old children participating in the School-Based Asthma Therapy trial. Using a time-stratified case-crossover design and conditional logistic regression, we estimated the relative odds of a pediatric asthma visit treated with prednisone (n=96 visits among 74 children) associated with increased pollutant concentrations in the previous 7 days. We re-ran these analyses separately for children receiving medications through the school-based intervention and children in a usual care control group. RESULTS: Interquartile range increases in ultrafine particles and carbon monoxide concentrations in the previous 7 days were associated with increases in the relative odds of a pediatric asthma visit, with the largest increases observed for 4-day mean ultrafine particles (interquartile range=2088p/cm(3); OR=1.27; 95% CI=0.90-1.79) and 7-day mean carbon monoxide (interquartile range=0.17ppm; OR=1.63; 95% CI=1.03-2.59). Relative odds estimates were larger among children receiving school-based inhaled corticosteroid treatment. We observed no such associations with accumulation mode particles, black carbon, fine particles (≤2.5μm), or sulfur dioxide. Ozone concentrations were inversely associated with the relative odds of a pediatric asthma visit. CONCLUSIONS: These findings suggest a response to markers of traffic pollution among urban asthmatic children. Effects were strongest among children receiving preventive medications through school, suggesting that this group of children was particularly sensitive to environmental triggers. Medication adherence alone may be insufficient to protect the most vulnerable from environmental asthma triggers. However, further research is necessary to confirm this finding.
OBJECTIVES: Increased air pollutant concentrations have been linked to several asthma-related outcomes in children, including respiratory symptoms, medication use, and hospital visits. However, few studies have examined effects of ultrafine particles in a pediatric population. Our primary objective was to examine the effects of ambient concentrations of ultrafine particles on asthma exacerbation among urban children and determine whether consistent treatment with inhaled corticosteroids could attenuate these effects. We also explored the relationship between asthma exacerbation and ambient concentrations of accumulation mode particles, fine particles (≤2.5 micrograms [μm]; PM2.5), carbon monoxide, sulfur dioxide, and ozone. We hypothesized that increased 1-7 day concentrations of ultrafine particles and other pollutants would be associated with increases in the relative odds of an asthma exacerbation, but that this increase in risk would be attenuated among children receiving school-based corticosteroid therapy. METHODS: We conducted a pilot study using data from 3 to 10 year-old children participating in the School-Based Asthma Therapy trial. Using a time-stratified case-crossover design and conditional logistic regression, we estimated the relative odds of a pediatric asthma visit treated with prednisone (n=96 visits among 74 children) associated with increased pollutant concentrations in the previous 7 days. We re-ran these analyses separately for children receiving medications through the school-based intervention and children in a usual care control group. RESULTS: Interquartile range increases in ultrafine particles and carbon monoxide concentrations in the previous 7 days were associated with increases in the relative odds of a pediatric asthma visit, with the largest increases observed for 4-day mean ultrafine particles (interquartile range=2088p/cm(3); OR=1.27; 95% CI=0.90-1.79) and 7-day mean carbon monoxide (interquartile range=0.17ppm; OR=1.63; 95% CI=1.03-2.59). Relative odds estimates were larger among children receiving school-based inhaled corticosteroid treatment. We observed no such associations with accumulation mode particles, black carbon, fine particles (≤2.5μm), or sulfur dioxide. Ozone concentrations were inversely associated with the relative odds of a pediatric asthma visit. CONCLUSIONS: These findings suggest a response to markers of traffic pollution among urban asthmatic children. Effects were strongest among children receiving preventive medications through school, suggesting that this group of children was particularly sensitive to environmental triggers. Medication adherence alone may be insufficient to protect the most vulnerable from environmental asthma triggers. However, further research is necessary to confirm this finding.
Authors: J J de Hartog; G Hoek; A Peters; K L Timonen; A Ibald-Mulli; B Brunekreef; J Heinrich; P Tiittanen; J H van Wijnen; W Kreyling; M Kulmala; J Pekkanen Journal: Am J Epidemiol Date: 2003-04-01 Impact factor: 4.897
Authors: Jennifer E Zora; Stefanie Ebelt Sarnat; Amit U Raysoni; Brent A Johnson; Wen-Whai Li; Roby Greenwald; Fernando Holguin; Thomas H Stock; Jeremy A Sarnat Journal: Sci Total Environ Date: 2013-01-09 Impact factor: 7.963
Authors: Janneane F Gent; Elizabeth W Triche; Theodore R Holford; Kathleen Belanger; Michael B Bracken; William S Beckett; Brian P Leaderer Journal: JAMA Date: 2003-10-08 Impact factor: 56.272
Authors: David C Chalupa; Paul E Morrow; Günter Oberdörster; Mark J Utell; Mark W Frampton Journal: Environ Health Perspect Date: 2004-06 Impact factor: 9.031
Authors: J L Allen; G Oberdorster; K Morris-Schaffer; C Wong; C Klocke; M Sobolewski; K Conrad; M Mayer-Proschel; D A Cory-Slechta Journal: Neurotoxicology Date: 2015-12-22 Impact factor: 4.294
Authors: Franziska Rosser; Erick Forno; Kristen S Kurland; Yueh-Ying Han; Christina Mair; Edna Acosta-Pérez; Glorisa Canino; Juan C Celedón Journal: Pediatr Pulmonol Date: 2019-12-05
Authors: Sara D Adar; Jennifer D'Souza; Lianne Sheppard; Joel D Kaufman; Teal S Hallstrand; Mark E Davey; James R Sullivan; Jordan Jahnke; Jane Koenig; Timothy V Larson; L J Sally Liu Journal: Am J Respir Crit Care Med Date: 2015-06-15 Impact factor: 21.405
Authors: Ning Li; Steve Georas; Neil Alexis; Patricia Fritz; Tian Xia; Marc A Williams; Elliott Horner; Andre Nel Journal: J Allergy Clin Immunol Date: 2016-04-06 Impact factor: 10.793
Authors: Adan Z Becerra; Steve Georas; J Thomas Brenna; Philip K Hopke; Cathleen Kane; David Chalupa; Mark W Frampton; Robert Block; David Q Rich Journal: J Toxicol Environ Health A Date: 2016-03-30